FAIR Therapeutics Overview
- Year Founded
-
2021
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
FAIR Therapeutics General Information
Description
Developer of CFTR modulator therapies designed for the treatment of people living with cystic fibrosis. The company focuses on an accessible, personalized approach using modulator therapies and an organoid model that mimics the human intestines to predict individual CF drug responses, enabling medical researchers to make drug development for ultra-rare mutations feasible and eliminating the need for clinical trials in small patient populations.
Contact Information
Website
www.fairtherapeutics.comCorporate Office
- Newtonlaan 115- 007
- 3584 BH Utrecht
- Netherlands
Corporate Office
- Newtonlaan 115- 007
- 3584 BH Utrecht
- Netherlands
FAIR Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 26-Sep-2026 | Completed | Out of Business | |||
| 1. Early Stage VC | 01-Jan-2024 | Completed | Clinical Trials - Phase 2 |
FAIR Therapeutics FAQs
-
When was FAIR Therapeutics founded?
FAIR Therapeutics was founded in 2021.
-
Where is FAIR Therapeutics headquartered?
FAIR Therapeutics is headquartered in Utrecht, Netherlands.
-
What industry is FAIR Therapeutics in?
FAIR Therapeutics’s primary industry is Biotechnology.
-
Is FAIR Therapeutics a private or public company?
FAIR Therapeutics is a Private company.
-
What is FAIR Therapeutics’s current revenue?
The current revenue for FAIR Therapeutics is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process